AMRX(AMRX)
AMRX
Q4 2026 EPS Estimate
$0.26
Oct 29, 2026 · Reports before open
Revenue Estimate
$809M
FY2026E EPS$0.99
FY2027E EPS$1.17
Analyst Sentiment
Wall St. Consensus
Buy16 analysts·Moderate coverage
67
Score
11 Buy (69%)5 Hold (31%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1169%
Hold
531%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$16.00
-12.0%
Consensus
$19.00
+4.5%
Bull
$25.00
+37.4%
12-Month Target Range16 analysts
$16.00$19.00$25.00
Current $18.19Consensus
Current Price
$18.19
Upside to Consensus
$0.81
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7.32%
EPS+18.49%
FY2028
Rev+8.13%
EPS+20.61%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $3.14B | $3.37B | $3.65B |
| Low | $3.12B | $3.35B | $3.61B |
| High | $3.17B | $3.38B | $3.68B |
| EBITDA Avg | $601M | $646M | $698M |
| Low | $598M | $642M | $692M |
| High | $607M | $647M | $704M |
| EBIT Avg | $303M | $326M | $352M |
| Low | $301M | $324M | $349M |
| High | $306M | $327M | $355M |
| Net Income Avg | $321M | $381M | $460M |
| Low | $318M | $377M | $453M |
| High | $325M | $384M | $466M |
| EPS Avg | $0.99 | $1.17 | $1.41 |
| Low | $0.98 | $1.16 | $1.40 |
| High | $1.00 | $1.18 | $1.44 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 4 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $809M | $823M | $765M | $825M | $865M | $944M |
| Low | $807M | $822M | $757M | $815M | $855M | $934M |
| High | $811M | $823M | $773M | $833M | $873M | $953M |
| EBITDA Avg | $155M | $158M | $146M | $158M | $166M | $181M |
| Low | $155M | $157M | $145M | $156M | $164M | $179M |
| High | $155M | $158M | $148M | $159M | $167M | $183M |
| EBIT Avg | $78M | $79M | $74M | $80M | $83M | $91M |
| Low | $78M | $79M | $73M | $79M | $83M | $90M |
| High | $78M | $79M | $75M | $80M | $84M | $92M |
| Net Income Avg | $75M | $79M | $84M | $90M | $99M | $117M |
| Low | $69M | $70M | $82M | $89M | $97M | $116M |
| High | $78M | $84M | $85M | $91M | $100M | $119M |
| EPS Avg | $0.23 | $0.24 | $0.25 | $0.27 | $0.30 | $0.36 |
| Low | $0.21 | $0.21 | $0.25 | $0.27 | $0.30 | $0.35 |
| High | $0.24 | $0.26 | $0.26 | $0.28 | $0.30 | $0.36 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |